pI: 10.4411 |
Length (AA): 283 |
MW (Da): 31286 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127301)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G58730 | V-type proton ATPase subunit D |
Babesia bovis | BBOV_III004650 | V-type ATPase, D subunit family protein |
Brugia malayi | Bm1_13590 | vacuolar ATP synthase subunit D |
Candida albicans | CaO19.10413 | similar to S. cerevisiae VMA8 (YEL051W) vacuolar ATPase V1 domain subunit D |
Candida albicans | CaO19.2895 | similar to S. cerevisiae VMA8 (YEL051W) vacuolar ATPase V1 domain subunit D |
Caenorhabditis elegans | CELE_F55H2.2 | Protein VHA-14 |
Cryptosporidium hominis | Chro.50340 | vacuolar ATP synthase subunit D |
Cryptosporidium parvum | cgd5_530 | vacuolar H-ATpase subunit D |
Dictyostelium discoideum | DDB_G0274331 | vacuolar ATP synthase subunit D |
Drosophila melanogaster | Dmel_CG13167 | Vacuolar H[+] ATPase 36kD subunit 2 |
Drosophila melanogaster | Dmel_CG8186 | Vacuolar H[+] ATPase 36kD subunit 1 |
Drosophila melanogaster | Dmel_CG8310 | Vacuolar H[+] ATPase 36kD subunit 3 |
Echinococcus granulosus | EgrG_000413100 | V type proton ATPase subunit D |
Entamoeba histolytica | EHI_056390 | V-type ATPase, D subunit, putative |
Echinococcus multilocularis | EmuJ_000413100 | V type proton ATPase subunit D |
Giardia lamblia | GL50803_3678 | Vacuolar ATP synthase subunit D |
Homo sapiens | 51382 | ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D |
Leishmania braziliensis | LbrM.34.0690 | vacuolar ATP synthase subunit d, putative |
Leishmania donovani | LdBPK_350710.1 | vacuolar ATP synthase subunit d, putative |
Leishmania infantum | LinJ.35.0710 | vacuolar ATP synthase subunit d, putative |
Leishmania major | LmjF.35.0700 | vacuolar ATP synthase subunit d, putative |
Leishmania mexicana | LmxM.34.0700 | vacuolar ATP synthase subunit d, putative |
Loa Loa (eye worm) | LOAG_07514 | vacuolar ATP synthase subunit D |
Mus musculus | ENSMUSG00000021114 | ATPase, H+ transporting, lysosomal V1 subunit D |
Neospora caninum | NCLIV_023610 | vacuolar ATP synthase subunit d, putative |
Oryza sativa | 4337176 | Os04g0643100 |
Plasmodium berghei | PBANKA_1355000 | V-type proton ATPase subunit D, putative |
Plasmodium falciparum | PF3D7_1341900 | V-type proton ATPase subunit D, putative |
Plasmodium knowlesi | PKNH_1259500 | V-type proton ATPase subunit D, putative |
Plasmodium vivax | PVX_082995 | vacuolar ATP synthase subunit d, putative |
Plasmodium yoelii | PY03087 | V-type ATPase, D subunit |
Saccharomyces cerevisiae | YEL051W | H(+)-transporting V1 sector ATPase subunit D |
Schistosoma japonicum | Sjp_0007070 | ko:K02149 V-type H+-transporting ATPase subunit D, putative |
Schistosoma mansoni | Smp_103200 | ATP synthase subunit d |
Schmidtea mediterranea | mk4.000818.00 | V-type proton ATPase subunit D |
Trypanosoma brucei gambiense | Tbg972.10.4680 | vacuolar ATP synthase subunit d, putative |
Trypanosoma brucei | Tb927.10.3760 | vacuolar ATP synthase subunit d, putative |
Trypanosoma congolense | TcIL3000_10_3090 | vacuolar ATP synthase subunit d, putative |
Trypanosoma cruzi | TcCLB.511001.190 | vacuolar ATP synthase subunit d, putative |
Trypanosoma cruzi | TcCLB.509017.30 | vacuolar ATP synthase subunit d |
Toxoplasma gondii | TGME49_281920 | V-type ATPase, D subunit protein |
Treponema pallidum | TP0527 | V-type ATPase, subunit D (atpD-2) |
Theileria parva | TP02_0488 | vacuolar ATP synthase subunit D, putative |
Trichomonas vaginalis | TVAG_038640 | ATP synthase subunit D, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.3760 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.3760 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.3760 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.3760 this record | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F55H2.2 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F55H2.2 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F55H2.2 | Caenorhabditis elegans | sterile | wormbase |
TGME49_281920 | Toxoplasma gondii | Probably essential | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
1 literature reference was collected for this gene.